JP2023539985A5 - - Google Patents

Info

Publication number
JP2023539985A5
JP2023539985A5 JP2023501029A JP2023501029A JP2023539985A5 JP 2023539985 A5 JP2023539985 A5 JP 2023539985A5 JP 2023501029 A JP2023501029 A JP 2023501029A JP 2023501029 A JP2023501029 A JP 2023501029A JP 2023539985 A5 JP2023539985 A5 JP 2023539985A5
Authority
JP
Japan
Prior art keywords
dihydro
phenyl
benzodiazepine
oxo
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023501029A
Other languages
English (en)
Japanese (ja)
Other versions
JP7840923B2 (ja
JP2023539985A (ja
Filing date
Publication date
Priority claimed from GBGB2010409.7A external-priority patent/GB202010409D0/en
Application filed filed Critical
Publication of JP2023539985A publication Critical patent/JP2023539985A/ja
Publication of JP2023539985A5 publication Critical patent/JP2023539985A5/ja
Application granted granted Critical
Publication of JP7840923B2 publication Critical patent/JP7840923B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023501029A 2020-07-07 2021-07-07 呼吸器合胞体ウイルス感染症の治療に有用なベンゾジアゼピン誘導体 Active JP7840923B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2010409.7 2020-07-07
GBGB2010409.7A GB202010409D0 (en) 2020-07-07 2020-07-07 Pharmaceutical compounds
PCT/GB2021/051731 WO2022008911A1 (en) 2020-07-07 2021-07-07 Benzodiazepine derivatives useful in treating a respiratory syncytial virus infection

Publications (3)

Publication Number Publication Date
JP2023539985A JP2023539985A (ja) 2023-09-21
JP2023539985A5 true JP2023539985A5 (cg-RX-API-DMAC7.html) 2024-06-25
JP7840923B2 JP7840923B2 (ja) 2026-04-06

Family

ID=72050502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023501029A Active JP7840923B2 (ja) 2020-07-07 2021-07-07 呼吸器合胞体ウイルス感染症の治療に有用なベンゾジアゼピン誘導体

Country Status (10)

Country Link
US (1) US12678446B2 (cg-RX-API-DMAC7.html)
EP (1) EP4178964A1 (cg-RX-API-DMAC7.html)
JP (1) JP7840923B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230035597A (cg-RX-API-DMAC7.html)
CN (1) CN116075516B (cg-RX-API-DMAC7.html)
BR (1) BR112023000142A2 (cg-RX-API-DMAC7.html)
CA (1) CA3188752A1 (cg-RX-API-DMAC7.html)
GB (1) GB202010409D0 (cg-RX-API-DMAC7.html)
MX (1) MX2023000440A (cg-RX-API-DMAC7.html)
WO (1) WO2022008911A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201911944D0 (en) 2019-08-20 2019-10-02 Reviral Ltd Pharmaceutical compounds
GB201915932D0 (en) 2019-11-01 2019-12-18 Reviral Ltd Pharmaceutical compounds
GB202010409D0 (en) 2020-07-07 2020-08-19 Reviral Ltd Pharmaceutical compounds
GB202102602D0 (en) 2021-02-24 2021-04-07 Reviral Ltd Pharmaceutical compounds
WO2024252355A1 (en) 2023-06-08 2024-12-12 Pfizer Inc. Pediatric dosing regimens comprising a fusion inhibitor for the treatment of rsv
WO2025120500A1 (en) 2023-12-06 2025-06-12 Pfizer Inc. Benzodiazepine compounds as n-protein inhibitors
CN122580320A (zh) 2024-01-16 2026-08-14 辉瑞大药厂 作为n-蛋白抑制剂的苯二氮䓬吡唑甲酰胺类
CN121621343B (zh) * 2026-02-02 2026-05-15 云南大学 一种化合物在防控植物病原真菌尖孢镰刀菌上的应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01011052A (es) * 1999-04-30 2002-11-22 Univ Michigan Aplicaciones terapeuticas de benzodiazepinas pro-apoctoticas.
BR0314595A (pt) * 2002-09-20 2005-08-09 Arrow Therapeutics Ltd Uso de um derivado de benzodiazepina ou um sal farmaceuticamente aceitável deste, inalador ou nebulisador, produto, usos de um produto e de um composto ou sal farmaceuticamente aceitável deste, derivado de benzodiazepina, composto, e, composição farmacêutica
ATE410161T1 (de) 2003-05-02 2008-10-15 Elan Pharm Inc 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazol-3- carbonsäureamid-derivate und verwandte verbindungen als bradykinin b1 rezeptor antagonisten zur behandlung von entzündlichen erkrankungen
GB0312365D0 (en) 2003-05-30 2003-07-02 Univ Aston Novel 3-substituted-1, 4-benzodiazepines
US20070293482A1 (en) 2004-03-19 2007-12-20 Novartis Pharmaceuticals Corporation Process for Preparing Benzodiazepines
GB0406280D0 (en) 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
GB0406282D0 (en) 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0406279D0 (en) 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
US20070032475A1 (en) 2005-04-15 2007-02-08 Ye Xiaocong M Novel compounds useful for bradykinin B1 receptor antagonism
TW201113262A (en) 2009-09-03 2011-04-16 Arrow Therapeutics Ltd Chemical compounds
WO2011151651A1 (en) 2010-06-03 2011-12-08 Arrow Therapeutics Limited Benzodiazepine compounds useful for the treatment of hepatitis c
WO2011151652A1 (en) 2010-06-03 2011-12-08 Arrow Therapeutics Limited Benzodiazepine compounds useful for the treatment of hepatitis c
GB201506448D0 (en) 2015-04-16 2015-06-03 Univ Durham An antimicrobial compound
MY197231A (en) * 2015-07-22 2023-06-06 Enanta Pharm Inc Benzodiazepine derivatives as rsv inhibitors
GB201613942D0 (en) 2016-08-15 2016-09-28 Univ Of Durham The An antimicrobial compound
WO2018085378A1 (en) 2016-11-01 2018-05-11 Milliken & Company Leuco polymers as bluing agents in laundry care compositions
WO2018129287A1 (en) 2017-01-06 2018-07-12 Enanta Pharmaceuticals, Inc. Heteroaryldiazepine derivatives as rsv inhibitors
WO2018152413A1 (en) 2017-02-16 2018-08-23 Enanta Pharmaceuticals, Inc. Processes for the preparation of benzodiazepine derivatives
WO2018226801A1 (en) 2017-06-07 2018-12-13 Enanta Pharmaceuticals, Inc. Aryldiazepine derivatives as rsv inhibitors
KR101970214B1 (ko) * 2017-07-17 2019-08-27 이화여자대학교 산학협력단 유기금속 화합물, 이들의 자기 조립체 및 이를 포함한 종양 진단 또는 치료용 조성물
WO2019094920A1 (en) 2017-11-13 2019-05-16 Enanta Pharmaceuticals, Inc. Azepin-2-one derivatives as rsv inhibitors
EP3781571B1 (en) * 2018-04-20 2024-01-17 F. Hoffmann-La Roche AG N-[4-oxo-2,3-dihydro-pyrido[3,2-b][1,4]oxazepin-3-yl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole-2-carboxamide derivatives and related compounds as rip1 kinase inhibitors for treating e.g. irritable bowel syndrome (ibs)
WO2020190935A1 (en) 2019-03-18 2020-09-24 Enanta Pharmaceuticals, Inc. Benzodiazepine derivatives as rsv inhibitors
GB201911944D0 (en) 2019-08-20 2019-10-02 Reviral Ltd Pharmaceutical compounds
GB201915273D0 (en) * 2019-10-22 2019-12-04 Reviral Ltd Pharmaceutical compounds
GB201915932D0 (en) 2019-11-01 2019-12-18 Reviral Ltd Pharmaceutical compounds
GB202010409D0 (en) 2020-07-07 2020-08-19 Reviral Ltd Pharmaceutical compounds
GB202010408D0 (en) 2020-07-07 2020-08-19 Reviral Ltd Pharmaceutical compounds

Similar Documents

Publication Publication Date Title
JP6509838B2 (ja) Btk阻害薬としての一級カルボキサミド類
JP5805763B2 (ja) C型肝炎ウイルス阻害剤
JP7860103B2 (ja) 複素環式スピロ化合物及びその使用方法
AU2016282289B2 (en) HPK1 inhibitors and methods of using same
BR112020008839A2 (pt) moduladores da via de estresse integrada
CN120712271A (zh) 作为kras g12d抑制剂的新型三环化合物及其用途
JP5977819B2 (ja) C型肝炎ウイルス阻害剤
CA3085590A1 (en) Substituted indole compounds useful as tlr inhibitors
JP2022542396A5 (cg-RX-API-DMAC7.html)
JP2013522286A5 (cg-RX-API-DMAC7.html)
TWI865582B (zh) [1,2,4]三唑并[1,5-c]喹唑啉-5-胺
JP2013515729A5 (cg-RX-API-DMAC7.html)
RU2018123779A (ru) Новые соединения
CA2877149A1 (en) Substituted pyridine azolopyrimidine-5-(6h)-one compounds
JP2007537296A (ja) 治療薬としてのキナーゼ阻害薬
CN107849024A (zh) 具有作为吲哚胺2,3‑二加氧酶抑制剂活性的苯并咪唑和咪唑并吡啶亚氨代甲酰胺化合物
ME02409B (me) Novi heterociklični derivati i njihova upotreba u tretmanu neuroloških poremećaja
CA3052718A1 (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
WO2015161288A1 (en) Tricyclic lactams for use as anti-neoplastic and anti-proliferative agents
KR102697255B1 (ko) 벤즈이미다졸 유도체 및 이의 용도
JP7840923B2 (ja) 呼吸器合胞体ウイルス感染症の治療に有用なベンゾジアゼピン誘導体
CN113508115A (zh) 吡啶并嘧啶酮和蝶啶酮化合物作为需要酶i(ire i α)的内切核糖核酸酶肌醇的抑制剂用于治疗癌症疾病
JP2013533868A (ja) タンパク質チロシンキナーゼ阻害剤としての新規ホモピペラジン誘導体およびそれらの医薬使用
RU2017113026A (ru) Спироиндолиновые соединения для лечения и профилактики респираторно-синцитиального вируса (rsv)
TWI750855B (zh) 嘧啶醯胺化合物及其用途